0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Febuxostat Tablets Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-38R7701
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Febuxostat Tablets Market Insights and Forecast to 2028
BUY CHAPTERS

Global Febuxostat Tablets Market Research Report 2025

Code: QYRE-Auto-38R7701
Report
July 2025
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Febuxostat Tablets Market

The global market for Febuxostat Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The main component of non-bubuxostat is non-bubuxostat, and its chemical name is 2-[(3-cyanogroup - 4-isobutyl oxygen group) phenyl] -4-methyl-5-thiazole carboxylic acid.Xanthine oxidase (XO) inhibitor for the long-term treatment of hyperuricemia with gout symptoms.
North American market for Febuxostat Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Febuxostat Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Febuxostat Tablets include Menarini Group, Takeda Pharmaceuticals, MACLEODS, Prinston Pharmaceutical, Alembic Pharmaceuticals, Hikma Pharmaceuticals, Lupin Limited, Mylan, Teijin Pharma, Hengrui Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Febuxostat Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Febuxostat Tablets.
The Febuxostat Tablets market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Febuxostat Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Febuxostat Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Febuxostat Tablets Market Report

Report Metric Details
Report Name Febuxostat Tablets Market
Segment by Type
  • 40 Mg Tablet
  • 80 Mg Tablet
  • 120 Mg Tablet
  • 20 Mg Tablet
Segment by Application
  • Hyperuricemia
  • Tumor Lysis Syndrome
  • Angina Pectoris
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Menarini Group, Takeda Pharmaceuticals, MACLEODS, Prinston Pharmaceutical, Alembic Pharmaceuticals, Hikma Pharmaceuticals, Lupin Limited, Mylan, Teijin Pharma, Hengrui Pharma, Sun Pharma, Msn Laboratories, Golden State Medical, Novadoz Pharmaceuticals, Astellas Pharma, SK Holdings, Ipsen, Hangzhou Zhuyangxin Pharmaceutical, Jiangsu Wanbang Biochemical Pharmaceutical Group, Tianjin Pacific Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Febuxostat Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Febuxostat Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Febuxostat Tablets Market report?

Ans: The main players in the Febuxostat Tablets Market are Menarini Group, Takeda Pharmaceuticals, MACLEODS, Prinston Pharmaceutical, Alembic Pharmaceuticals, Hikma Pharmaceuticals, Lupin Limited, Mylan, Teijin Pharma, Hengrui Pharma, Sun Pharma, Msn Laboratories, Golden State Medical, Novadoz Pharmaceuticals, Astellas Pharma, SK Holdings, Ipsen, Hangzhou Zhuyangxin Pharmaceutical, Jiangsu Wanbang Biochemical Pharmaceutical Group, Tianjin Pacific Pharmaceutical

What are the Application segmentation covered in the Febuxostat Tablets Market report?

Ans: The Applications covered in the Febuxostat Tablets Market report are Hyperuricemia, Tumor Lysis Syndrome, Angina Pectoris, Other

What are the Type segmentation covered in the Febuxostat Tablets Market report?

Ans: The Types covered in the Febuxostat Tablets Market report are 40 Mg Tablet, 80 Mg Tablet, 120 Mg Tablet, 20 Mg Tablet

1 Febuxostat Tablets Market Overview
1.1 Product Definition
1.2 Febuxostat Tablets by Type
1.2.1 Global Febuxostat Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 40 Mg Tablet
1.2.3 80 Mg Tablet
1.2.4 120 Mg Tablet
1.2.5 20 Mg Tablet
1.3 Febuxostat Tablets by Application
1.3.1 Global Febuxostat Tablets Market Value by Application (2024 VS 2031)
1.3.2 Hyperuricemia
1.3.3 Tumor Lysis Syndrome
1.3.4 Angina Pectoris
1.3.5 Other
1.4 Global Febuxostat Tablets Market Size Estimates and Forecasts
1.4.1 Global Febuxostat Tablets Revenue 2020-2031
1.4.2 Global Febuxostat Tablets Sales 2020-2031
1.4.3 Global Febuxostat Tablets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Febuxostat Tablets Market Competition by Manufacturers
2.1 Global Febuxostat Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Febuxostat Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Febuxostat Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Febuxostat Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Febuxostat Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Febuxostat Tablets, Product Type & Application
2.7 Global Key Manufacturers of Febuxostat Tablets, Date of Enter into This Industry
2.8 Global Febuxostat Tablets Market Competitive Situation and Trends
2.8.1 Global Febuxostat Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Febuxostat Tablets Players Market Share by Revenue
2.8.3 Global Febuxostat Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Febuxostat Tablets Market Scenario by Region
3.1 Global Febuxostat Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Febuxostat Tablets Sales by Region: 2020-2031
3.2.1 Global Febuxostat Tablets Sales by Region: 2020-2025
3.2.2 Global Febuxostat Tablets Sales by Region: 2026-2031
3.3 Global Febuxostat Tablets Revenue by Region: 2020-2031
3.3.1 Global Febuxostat Tablets Revenue by Region: 2020-2025
3.3.2 Global Febuxostat Tablets Revenue by Region: 2026-2031
3.4 North America Febuxostat Tablets Market Facts & Figures by Country
3.4.1 North America Febuxostat Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Febuxostat Tablets Sales by Country (2020-2031)
3.4.3 North America Febuxostat Tablets Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Febuxostat Tablets Market Facts & Figures by Country
3.5.1 Europe Febuxostat Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Febuxostat Tablets Sales by Country (2020-2031)
3.5.3 Europe Febuxostat Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Febuxostat Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Febuxostat Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Febuxostat Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Febuxostat Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Febuxostat Tablets Market Facts & Figures by Country
3.7.1 Latin America Febuxostat Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Febuxostat Tablets Sales by Country (2020-2031)
3.7.3 Latin America Febuxostat Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Febuxostat Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Febuxostat Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Febuxostat Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Febuxostat Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Febuxostat Tablets Sales by Type (2020-2031)
4.1.1 Global Febuxostat Tablets Sales by Type (2020-2025)
4.1.2 Global Febuxostat Tablets Sales by Type (2026-2031)
4.1.3 Global Febuxostat Tablets Sales Market Share by Type (2020-2031)
4.2 Global Febuxostat Tablets Revenue by Type (2020-2031)
4.2.1 Global Febuxostat Tablets Revenue by Type (2020-2025)
4.2.2 Global Febuxostat Tablets Revenue by Type (2026-2031)
4.2.3 Global Febuxostat Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Febuxostat Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Febuxostat Tablets Sales by Application (2020-2031)
5.1.1 Global Febuxostat Tablets Sales by Application (2020-2025)
5.1.2 Global Febuxostat Tablets Sales by Application (2026-2031)
5.1.3 Global Febuxostat Tablets Sales Market Share by Application (2020-2031)
5.2 Global Febuxostat Tablets Revenue by Application (2020-2031)
5.2.1 Global Febuxostat Tablets Revenue by Application (2020-2025)
5.2.2 Global Febuxostat Tablets Revenue by Application (2026-2031)
5.2.3 Global Febuxostat Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Febuxostat Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Menarini Group
6.1.1 Menarini Group Company Information
6.1.2 Menarini Group Description and Business Overview
6.1.3 Menarini Group Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Menarini Group Febuxostat Tablets Product Portfolio
6.1.5 Menarini Group Recent Developments/Updates
6.2 Takeda Pharmaceuticals
6.2.1 Takeda Pharmaceuticals Company Information
6.2.2 Takeda Pharmaceuticals Description and Business Overview
6.2.3 Takeda Pharmaceuticals Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Takeda Pharmaceuticals Febuxostat Tablets Product Portfolio
6.2.5 Takeda Pharmaceuticals Recent Developments/Updates
6.3 MACLEODS
6.3.1 MACLEODS Company Information
6.3.2 MACLEODS Description and Business Overview
6.3.3 MACLEODS Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 MACLEODS Febuxostat Tablets Product Portfolio
6.3.5 MACLEODS Recent Developments/Updates
6.4 Prinston Pharmaceutical
6.4.1 Prinston Pharmaceutical Company Information
6.4.2 Prinston Pharmaceutical Description and Business Overview
6.4.3 Prinston Pharmaceutical Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Prinston Pharmaceutical Febuxostat Tablets Product Portfolio
6.4.5 Prinston Pharmaceutical Recent Developments/Updates
6.5 Alembic Pharmaceuticals
6.5.1 Alembic Pharmaceuticals Company Information
6.5.2 Alembic Pharmaceuticals Description and Business Overview
6.5.3 Alembic Pharmaceuticals Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Alembic Pharmaceuticals Febuxostat Tablets Product Portfolio
6.5.5 Alembic Pharmaceuticals Recent Developments/Updates
6.6 Hikma Pharmaceuticals
6.6.1 Hikma Pharmaceuticals Company Information
6.6.2 Hikma Pharmaceuticals Description and Business Overview
6.6.3 Hikma Pharmaceuticals Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hikma Pharmaceuticals Febuxostat Tablets Product Portfolio
6.6.5 Hikma Pharmaceuticals Recent Developments/Updates
6.7 Lupin Limited
6.7.1 Lupin Limited Company Information
6.7.2 Lupin Limited Description and Business Overview
6.7.3 Lupin Limited Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Lupin Limited Febuxostat Tablets Product Portfolio
6.7.5 Lupin Limited Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Company Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Mylan Febuxostat Tablets Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Teijin Pharma
6.9.1 Teijin Pharma Company Information
6.9.2 Teijin Pharma Description and Business Overview
6.9.3 Teijin Pharma Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Teijin Pharma Febuxostat Tablets Product Portfolio
6.9.5 Teijin Pharma Recent Developments/Updates
6.10 Hengrui Pharma
6.10.1 Hengrui Pharma Company Information
6.10.2 Hengrui Pharma Description and Business Overview
6.10.3 Hengrui Pharma Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hengrui Pharma Febuxostat Tablets Product Portfolio
6.10.5 Hengrui Pharma Recent Developments/Updates
6.11 Sun Pharma
6.11.1 Sun Pharma Company Information
6.11.2 Sun Pharma Description and Business Overview
6.11.3 Sun Pharma Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sun Pharma Febuxostat Tablets Product Portfolio
6.11.5 Sun Pharma Recent Developments/Updates
6.12 Msn Laboratories
6.12.1 Msn Laboratories Company Information
6.12.2 Msn Laboratories Description and Business Overview
6.12.3 Msn Laboratories Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Msn Laboratories Febuxostat Tablets Product Portfolio
6.12.5 Msn Laboratories Recent Developments/Updates
6.13 Golden State Medical
6.13.1 Golden State Medical Company Information
6.13.2 Golden State Medical Description and Business Overview
6.13.3 Golden State Medical Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Golden State Medical Febuxostat Tablets Product Portfolio
6.13.5 Golden State Medical Recent Developments/Updates
6.14 Novadoz Pharmaceuticals
6.14.1 Novadoz Pharmaceuticals Company Information
6.14.2 Novadoz Pharmaceuticals Description and Business Overview
6.14.3 Novadoz Pharmaceuticals Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Novadoz Pharmaceuticals Febuxostat Tablets Product Portfolio
6.14.5 Novadoz Pharmaceuticals Recent Developments/Updates
6.15 Astellas Pharma
6.15.1 Astellas Pharma Company Information
6.15.2 Astellas Pharma Description and Business Overview
6.15.3 Astellas Pharma Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Astellas Pharma Febuxostat Tablets Product Portfolio
6.15.5 Astellas Pharma Recent Developments/Updates
6.16 SK Holdings
6.16.1 SK Holdings Company Information
6.16.2 SK Holdings Description and Business Overview
6.16.3 SK Holdings Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.16.4 SK Holdings Febuxostat Tablets Product Portfolio
6.16.5 SK Holdings Recent Developments/Updates
6.17 Ipsen
6.17.1 Ipsen Company Information
6.17.2 Ipsen Description and Business Overview
6.17.3 Ipsen Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Ipsen Febuxostat Tablets Product Portfolio
6.17.5 Ipsen Recent Developments/Updates
6.18 Hangzhou Zhuyangxin Pharmaceutical
6.18.1 Hangzhou Zhuyangxin Pharmaceutical Company Information
6.18.2 Hangzhou Zhuyangxin Pharmaceutical Description and Business Overview
6.18.3 Hangzhou Zhuyangxin Pharmaceutical Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Hangzhou Zhuyangxin Pharmaceutical Febuxostat Tablets Product Portfolio
6.18.5 Hangzhou Zhuyangxin Pharmaceutical Recent Developments/Updates
6.19 Jiangsu Wanbang Biochemical Pharmaceutical Group
6.19.1 Jiangsu Wanbang Biochemical Pharmaceutical Group Company Information
6.19.2 Jiangsu Wanbang Biochemical Pharmaceutical Group Description and Business Overview
6.19.3 Jiangsu Wanbang Biochemical Pharmaceutical Group Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Jiangsu Wanbang Biochemical Pharmaceutical Group Febuxostat Tablets Product Portfolio
6.19.5 Jiangsu Wanbang Biochemical Pharmaceutical Group Recent Developments/Updates
6.20 Tianjin Pacific Pharmaceutical
6.20.1 Tianjin Pacific Pharmaceutical Company Information
6.20.2 Tianjin Pacific Pharmaceutical Description and Business Overview
6.20.3 Tianjin Pacific Pharmaceutical Febuxostat Tablets Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Tianjin Pacific Pharmaceutical Febuxostat Tablets Product Portfolio
6.20.5 Tianjin Pacific Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Febuxostat Tablets Industry Chain Analysis
7.2 Febuxostat Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Febuxostat Tablets Production Mode & Process Analysis
7.4 Febuxostat Tablets Sales and Marketing
7.4.1 Febuxostat Tablets Sales Channels
7.4.2 Febuxostat Tablets Distributors
7.5 Febuxostat Tablets Customer Analysis
8 Febuxostat Tablets Market Dynamics
8.1 Febuxostat Tablets Industry Trends
8.2 Febuxostat Tablets Market Drivers
8.3 Febuxostat Tablets Market Challenges
8.4 Febuxostat Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Febuxostat Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Febuxostat Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Febuxostat Tablets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Febuxostat Tablets Sales (M Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Febuxostat Tablets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Febuxostat Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Febuxostat Tablets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Febuxostat Tablets Average Price (US$/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Febuxostat Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Febuxostat Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Febuxostat Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Febuxostat Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Febuxostat Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Febuxostat Tablets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Febuxostat Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Febuxostat Tablets Sales by Region (2020-2025) & (M Pcs)
 Table 18. Global Febuxostat Tablets Sales Market Share by Region (2020-2025)
 Table 19. Global Febuxostat Tablets Sales by Region (2026-2031) & (M Pcs)
 Table 20. Global Febuxostat Tablets Sales Market Share by Region (2026-2031)
 Table 21. Global Febuxostat Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Febuxostat Tablets Revenue Market Share by Region (2020-2025)
 Table 23. Global Febuxostat Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Febuxostat Tablets Revenue Market Share by Region (2026-2031)
 Table 25. North America Febuxostat Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Febuxostat Tablets Sales by Country (2020-2025) & (M Pcs)
 Table 27. North America Febuxostat Tablets Sales by Country (2026-2031) & (M Pcs)
 Table 28. North America Febuxostat Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Febuxostat Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Febuxostat Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Febuxostat Tablets Sales by Country (2020-2025) & (M Pcs)
 Table 32. Europe Febuxostat Tablets Sales by Country (2026-2031) & (M Pcs)
 Table 33. Europe Febuxostat Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Febuxostat Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Febuxostat Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Febuxostat Tablets Sales by Region (2020-2025) & (M Pcs)
 Table 37. Asia Pacific Febuxostat Tablets Sales by Region (2026-2031) & (M Pcs)
 Table 38. Asia Pacific Febuxostat Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Febuxostat Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Febuxostat Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Febuxostat Tablets Sales by Country (2020-2025) & (M Pcs)
 Table 42. Latin America Febuxostat Tablets Sales by Country (2026-2031) & (M Pcs)
 Table 43. Latin America Febuxostat Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Febuxostat Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Febuxostat Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Febuxostat Tablets Sales by Country (2020-2025) & (M Pcs)
 Table 47. Middle East and Africa Febuxostat Tablets Sales by Country (2026-2031) & (M Pcs)
 Table 48. Middle East and Africa Febuxostat Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Febuxostat Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Febuxostat Tablets Sales (M Pcs) by Type (2020-2025)
 Table 51. Global Febuxostat Tablets Sales (M Pcs) by Type (2026-2031)
 Table 52. Global Febuxostat Tablets Sales Market Share by Type (2020-2025)
 Table 53. Global Febuxostat Tablets Sales Market Share by Type (2026-2031)
 Table 54. Global Febuxostat Tablets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Febuxostat Tablets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Febuxostat Tablets Revenue Market Share by Type (2020-2025)
 Table 57. Global Febuxostat Tablets Revenue Market Share by Type (2026-2031)
 Table 58. Global Febuxostat Tablets Price (US$/Pcs) by Type (2020-2025)
 Table 59. Global Febuxostat Tablets Price (US$/Pcs) by Type (2026-2031)
 Table 60. Global Febuxostat Tablets Sales (M Pcs) by Application (2020-2025)
 Table 61. Global Febuxostat Tablets Sales (M Pcs) by Application (2026-2031)
 Table 62. Global Febuxostat Tablets Sales Market Share by Application (2020-2025)
 Table 63. Global Febuxostat Tablets Sales Market Share by Application (2026-2031)
 Table 64. Global Febuxostat Tablets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Febuxostat Tablets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Febuxostat Tablets Revenue Market Share by Application (2020-2025)
 Table 67. Global Febuxostat Tablets Revenue Market Share by Application (2026-2031)
 Table 68. Global Febuxostat Tablets Price (US$/Pcs) by Application (2020-2025)
 Table 69. Global Febuxostat Tablets Price (US$/Pcs) by Application (2026-2031)
 Table 70. Menarini Group Company Information
 Table 71. Menarini Group Description and Business Overview
 Table 72. Menarini Group Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 73. Menarini Group Febuxostat Tablets Product
 Table 74. Menarini Group Recent Developments/Updates
 Table 75. Takeda Pharmaceuticals Company Information
 Table 76. Takeda Pharmaceuticals Description and Business Overview
 Table 77. Takeda Pharmaceuticals Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 78. Takeda Pharmaceuticals Febuxostat Tablets Product
 Table 79. Takeda Pharmaceuticals Recent Developments/Updates
 Table 80. MACLEODS Company Information
 Table 81. MACLEODS Description and Business Overview
 Table 82. MACLEODS Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 83. MACLEODS Febuxostat Tablets Product
 Table 84. MACLEODS Recent Developments/Updates
 Table 85. Prinston Pharmaceutical Company Information
 Table 86. Prinston Pharmaceutical Description and Business Overview
 Table 87. Prinston Pharmaceutical Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 88. Prinston Pharmaceutical Febuxostat Tablets Product
 Table 89. Prinston Pharmaceutical Recent Developments/Updates
 Table 90. Alembic Pharmaceuticals Company Information
 Table 91. Alembic Pharmaceuticals Description and Business Overview
 Table 92. Alembic Pharmaceuticals Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 93. Alembic Pharmaceuticals Febuxostat Tablets Product
 Table 94. Alembic Pharmaceuticals Recent Developments/Updates
 Table 95. Hikma Pharmaceuticals Company Information
 Table 96. Hikma Pharmaceuticals Description and Business Overview
 Table 97. Hikma Pharmaceuticals Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 98. Hikma Pharmaceuticals Febuxostat Tablets Product
 Table 99. Hikma Pharmaceuticals Recent Developments/Updates
 Table 100. Lupin Limited Company Information
 Table 101. Lupin Limited Description and Business Overview
 Table 102. Lupin Limited Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 103. Lupin Limited Febuxostat Tablets Product
 Table 104. Lupin Limited Recent Developments/Updates
 Table 105. Mylan Company Information
 Table 106. Mylan Description and Business Overview
 Table 107. Mylan Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 108. Mylan Febuxostat Tablets Product
 Table 109. Mylan Recent Developments/Updates
 Table 110. Teijin Pharma Company Information
 Table 111. Teijin Pharma Description and Business Overview
 Table 112. Teijin Pharma Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 113. Teijin Pharma Febuxostat Tablets Product
 Table 114. Teijin Pharma Recent Developments/Updates
 Table 115. Hengrui Pharma Company Information
 Table 116. Hengrui Pharma Description and Business Overview
 Table 117. Hengrui Pharma Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 118. Hengrui Pharma Febuxostat Tablets Product
 Table 119. Hengrui Pharma Recent Developments/Updates
 Table 120. Sun Pharma Company Information
 Table 121. Sun Pharma Description and Business Overview
 Table 122. Sun Pharma Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 123. Sun Pharma Febuxostat Tablets Product
 Table 124. Sun Pharma Recent Developments/Updates
 Table 125. Msn Laboratories Company Information
 Table 126. Msn Laboratories Description and Business Overview
 Table 127. Msn Laboratories Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 128. Msn Laboratories Febuxostat Tablets Product
 Table 129. Msn Laboratories Recent Developments/Updates
 Table 130. Golden State Medical Company Information
 Table 131. Golden State Medical Description and Business Overview
 Table 132. Golden State Medical Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 133. Golden State Medical Febuxostat Tablets Product
 Table 134. Golden State Medical Recent Developments/Updates
 Table 135. Novadoz Pharmaceuticals Company Information
 Table 136. Novadoz Pharmaceuticals Description and Business Overview
 Table 137. Novadoz Pharmaceuticals Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 138. Novadoz Pharmaceuticals Febuxostat Tablets Product
 Table 139. Novadoz Pharmaceuticals Recent Developments/Updates
 Table 140. Astellas Pharma Company Information
 Table 141. Astellas Pharma Description and Business Overview
 Table 142. Astellas Pharma Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 143. Astellas Pharma Febuxostat Tablets Product
 Table 144. Astellas Pharma Recent Developments/Updates
 Table 145. SK Holdings Company Information
 Table 146. SK Holdings Description and Business Overview
 Table 147. SK Holdings Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 148. SK Holdings Febuxostat Tablets Product
 Table 149. SK Holdings Recent Developments/Updates
 Table 150. Ipsen Company Information
 Table 151. Ipsen Description and Business Overview
 Table 152. Ipsen Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 153. Ipsen Febuxostat Tablets Product
 Table 154. Ipsen Recent Developments/Updates
 Table 155. Hangzhou Zhuyangxin Pharmaceutical Company Information
 Table 156. Hangzhou Zhuyangxin Pharmaceutical Description and Business Overview
 Table 157. Hangzhou Zhuyangxin Pharmaceutical Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 158. Hangzhou Zhuyangxin Pharmaceutical Febuxostat Tablets Product
 Table 159. Hangzhou Zhuyangxin Pharmaceutical Recent Developments/Updates
 Table 160. Jiangsu Wanbang Biochemical Pharmaceutical Group Company Information
 Table 161. Jiangsu Wanbang Biochemical Pharmaceutical Group Description and Business Overview
 Table 162. Jiangsu Wanbang Biochemical Pharmaceutical Group Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 163. Jiangsu Wanbang Biochemical Pharmaceutical Group Febuxostat Tablets Product
 Table 164. Jiangsu Wanbang Biochemical Pharmaceutical Group Recent Developments/Updates
 Table 165. Tianjin Pacific Pharmaceutical Company Information
 Table 166. Tianjin Pacific Pharmaceutical Description and Business Overview
 Table 167. Tianjin Pacific Pharmaceutical Febuxostat Tablets Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 168. Tianjin Pacific Pharmaceutical Febuxostat Tablets Product
 Table 169. Tianjin Pacific Pharmaceutical Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Febuxostat Tablets Distributors List
 Table 173. Febuxostat Tablets Customers List
 Table 174. Febuxostat Tablets Market Trends
 Table 175. Febuxostat Tablets Market Drivers
 Table 176. Febuxostat Tablets Market Challenges
 Table 177. Febuxostat Tablets Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Febuxostat Tablets
 Figure 2. Global Febuxostat Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Febuxostat Tablets Market Share by Type: 2024 & 2031
 Figure 4. 40 Mg Tablet Product Picture
 Figure 5. 80 Mg Tablet Product Picture
 Figure 6. 120 Mg Tablet Product Picture
 Figure 7. 20 Mg Tablet Product Picture
 Figure 8. Global Febuxostat Tablets Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Febuxostat Tablets Market Share by Application: 2024 & 2031
 Figure 10. Hyperuricemia
 Figure 11. Tumor Lysis Syndrome
 Figure 12. Angina Pectoris
 Figure 13. Other
 Figure 14. Global Febuxostat Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Febuxostat Tablets Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Febuxostat Tablets Sales (2020-2031) & (M Pcs)
 Figure 17. Global Febuxostat Tablets Average Price (US$/Pcs) & (2020-2031)
 Figure 18. Febuxostat Tablets Report Years Considered
 Figure 19. Febuxostat Tablets Sales Share by Manufacturers in 2024
 Figure 20. Global Febuxostat Tablets Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Febuxostat Tablets Players: Market Share by Revenue in Febuxostat Tablets in 2024
 Figure 22. Febuxostat Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Febuxostat Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Febuxostat Tablets Sales Market Share by Country (2020-2031)
 Figure 25. North America Febuxostat Tablets Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Febuxostat Tablets Sales Market Share by Country (2020-2031)
 Figure 29. Europe Febuxostat Tablets Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Febuxostat Tablets Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Febuxostat Tablets Revenue Market Share by Region (2020-2031)
 Figure 37. China Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Febuxostat Tablets Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Febuxostat Tablets Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Febuxostat Tablets Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Febuxostat Tablets Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Febuxostat Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Febuxostat Tablets by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Febuxostat Tablets by Type (2020-2031)
 Figure 59. Global Febuxostat Tablets Price (US$/Pcs) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Febuxostat Tablets by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Febuxostat Tablets by Application (2020-2031)
 Figure 62. Global Febuxostat Tablets Price (US$/Pcs) by Application (2020-2031)
 Figure 63. Febuxostat Tablets Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart